Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP15 - Staging/Pulmonary Medicine

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Staging/Pulmonary Medicine
    • +

      FP15.01 - Randomized Single-Blind Comparative Study of Midazolam Plus Pethidine Combination and Midazolam During Bronchoscopy

      00:00 - 00:00  |  Presenter: Chihiro Mimura

      • Abstract

      Loading...

  • +

    FP16 - Tumor Biology and Systems Biology: Basic and Translational Science

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    • +

      FP16.01 - Development and Characterization of Two Novel Squamous Cell Lung Cancer Mouse Cell Lines

      00:00 - 00:00  |  Presenter: Karmele Valencia

      • Abstract

      Loading...

    • +

      FP16.02 - Genomic Characterization of Primary versus Metastatic Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: yanyan Lou

      • Abstract

      Loading...

    • +

      FP16.03 - Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial

      00:00 - 00:00  |  Presenter: Myung-Ju Ahn

      • Abstract

      Loading...

    • +

      FP16.04 - A Nationwide Population-Based Mapping of Mutations and Gene Fusions in Lung Cancer Among Never-Smokers

      00:00 - 00:00  |  Presenter: Annette Salomonsson

      • Abstract

      Loading...

    • +

      FP16.05 - Computational Omics Biology Model (CBM) Identifies Novel Biomarkers to Inform Combination Platinum Compound Therapy in NSCLC

      00:00 - 00:00  |  Presenter: Vamsidhar Velcheti

      • Abstract

      Loading...

  • +

    P01 - Early Stage/Localized Disease/Ablative Therapies - Adjuvant Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P01.01 - LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenter: Jonathan Goldman

      • Abstract

      Loading...

    • +

      P01.02 - High Risk Factors and Benefit of Adjuvant Chemotherapy in Surgically Resected Stage IB Non–Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: ELIZABETH BLESSING ELIMIMIAN

      • Abstract

      Loading...

  • +

    P02 - Early Stage/Localized Disease/Ablative Therapies - Bronchoscopy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P02.01 - CT Integrated Bronchoscopy Manual Spraying Pigment Labeling to Localize of Small Pulmonary Nodules

      00:00 - 00:00  |  Presenter: Jitian Zhang

      • Abstract

      Loading...

    • +

      P02.02 - Transbronchial Microwave Ablation of Lung Nodules in the Hybrid Operating Room – Mid-Term Follow Up of a Novel Technique

      00:00 - 00:00  |  Presenter: Joyce Wing Yan Chan

      • Abstract

      Loading...

    • +

      P02.03 - Robotic Bronchoscopy: Navigating the Change in Lung Nodule Management

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P02.04 - Three Cases of Endoscopic Snare Resection for Tracheal and Main Bronchial Tumors

      00:00 - 00:00  |  Presenter: Fumihiko Hoshi

      • Abstract

      Loading...

    • +

      P02.05 - Yield of Tumor Samples With A Guide-sheath in Endobronchial Ultrasound Transbronchial Biopsy For Non-small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Naoko Katsurada

      • Abstract

      Loading...

  • +

    P03 - Early Stage/Localized Disease/Ablative Therapies - Neoadjuvant Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P03.01 - Pathologic Response to Neoadjuvant PD-1 Inhibitors and Chemotherapy in Squamous Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Liang Shi

      • Abstract

      Loading...

    • +

      P03.02 - Osimertinib as Neoadjuvant Therapy for Resectable EGFR Mutant Non-small Cell Lung Cancer: A Real-World Multicenter Retrospective Study

      00:00 - 00:00  |  Presenter: Xue-Feng Leng

      • Abstract

      Loading...

  • +

    P04 - Early Stage/Localized Disease/Ablative Therapies - Nodule Evaluation

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P04.01 - Presence of Ground Glass Opacity Component is True Determinant of Prognosis in Clinical Stage I Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Akira Hamada

      • Abstract

      Loading...

    • +

      P04.02 - Efficacy of Multidisciplinary Team-Based Evaluation of Patients With Suspicious Pulmonary Lesions

      00:00 - 00:00  |  Presenter: Federico Mazza

      • Abstract

      Loading...

  • +

    P05 - Early Stage/Localized Disease/Ablative Therapies - SBRT

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P05.01 - Personalized Optimization of TCP Using NTCP Based Constraints for Ultracentral Lung Tumors

      00:00 - 00:00  |  Presenter: Aditi Iyer

      • Abstract

      Loading...

    • +

      P05.02 - Does Non-Small Cell Lung Cancer Histologic Type Influence Outcomes with Single-Fraction Stereotactic Body Radiotherapy?

      00:00 - 00:00  |  Presenter: Gregory Videtic

      • Abstract

      Loading...

    • +

      P05.03 - Comparison of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Early-Stage NSCLC: A Systemic Review and Pooled Analysis

      00:00 - 00:00  |  Presenter: Ran Zhang

      • Abstract

      Loading...

    • +

      P05.05 - Impact of Lung Stereotactic Body Radiotherapy on Pulmonary Function Test – Experience from Tertiary Cancer Centre in India

      00:00 - 00:00  |  Presenter: Prachi Vijay Sawant

      • Abstract

      Loading...

    • +

      P05.06 - Clinical Application of Anatomical Landmarkers Based 3D Precise Pulmonary Nodule Localization During Thoracoscopic Surgery

      00:00 - 00:00  |  Presenter: Dazhi Pang

      • Abstract

      Loading...

    • +

      P05.07 - Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer Without Pretreatment Pathologic Results in a Chinese Population

      00:00 - 00:00  |  Presenter: Ran Zhang

      • Abstract

      Loading...

  • +

    P06 - Early Stage/Localized Disease/Ablative Therapies - Surgery

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P06.01 - Propensity-Matched Analysis Comparing Survival after Thoracoscopic Wedge Resection versus Segmentectomy for cT1N0 Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Mong-Wei Lin

      • Abstract

      Loading...

    • +

      P06.02 - Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study.

      00:00 - 00:00  |  Presenter: Hans Blaauwgeers

      • Abstract

      Loading...

    • +

      P06.03 - The Role of Surgery for Stage 0 Adenocarcinoma in Situ of the Lung: A U.S. National Analysis 

      00:00 - 00:00  |  Presenter: Jessica M. Copeland

      • Abstract

      Loading...

    • +

      P06.04 - Clinical Outcomes and Pathological Characteristics of Resected ALK+ Lung Adenocarcinoma: A Single Center Retrospective Analysis

      00:00 - 00:00  |  Presenter: Zihua Zou

      • Abstract

      Loading...

    • +

      P06.05 - Risk Factors for Recurrence According to Site in Resected Stage I Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Satoshi Shiono

      • Abstract

      Loading...

    • +

      P06.06 - Clinical Implications of Tumour Spread Through Air Spaces (STAS) In Lung Adenocarcinoma Patients Treated With Surgery

      00:00 - 00:00  |  Presenter: Laura Gutierrez Sainz

      • Abstract

      Loading...

    • +

      P06.07 - Learning Curve in Robotic-Assisted Thoracoscopic Pulmonary Resection: Experience of a Brazilian Surgeon

      00:00 - 00:00  |  Presenter: Mariana Schettini Soares

      • Abstract

      Loading...

    • +

      P06.08 - Treatment Outcome of Second Primary Lung Cancer

      00:00 - 00:00  |  Presenter: Fumihiko Hoshi

      • Abstract

      Loading...

    • +

      P06.09 - Lobectomy for Lung Cancer, What Is the Brazilian reality? Brazilian Society of Thoracic Surgeons Analysis

      00:00 - 00:00  |  Presenter: Maria Teresa Ruiz Tsukazan

      • Abstract

      Loading...

    • +

      P06.10 - Low-Cost Video-Assisted Thoracic Surgery (VATS) Lobectomy Versus Regular VATS Lobectomy: A Propensity-Matched Study

      00:00 - 00:00  |  Presenter: Taiyang Liuru

      • Abstract

      Loading...

  • +

    P07 - Global Health

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Global Health
    • +

      P07.01 - Usage Patterns of TKIs in EGFR Mutant NSCLC: Let's Get REAL

      00:00 - 00:00  |  Presenter: Ullas Batra

      • Abstract

      Loading...

    • +

      P07.02 - Real World data of Advanced Non-Small Cell Lung Cancer Patients EGFR Mutated from a Peruvian Cohort

      00:00 - 00:00  |  Presenter: Marco Antonio Galvez-Nino

      • Abstract

      Loading...

    • +

      P07.03 - Lung Cancer Under 50 Years Old – What Reality Taught Us

      00:00 - 00:00  |  Presenter: Francisco Neri

      • Abstract

      Loading...

    • +

      P07.04 - Primary Lung Cancers in Patients With Head and Neck Cancer: Experience of a French Institution

      00:00 - 00:00  |  Presenter: Christelle Clément-Duchêne

      • Abstract

      Loading...

  • +

    P08 - Health Services Research/Health Economics - Factors Affecting Clinical Outcomes

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P08.01 - Building Personalized Follow-Up Care Through AI by Bringing the Lung Cancer Patient, Data Scientist and Oncologist Together

      00:00 - 00:00  |  Presenter: Maria Torrente

      • Abstract

      Loading...

    • +

      P08.02 - Lorlatinib in First Line Treatment of Patients With ALK-Positive NSCLC: A Network Meta-Analysis

      00:00 - 00:00  |  Presenter: Sai-Hong I. Ou

      • Abstract

      Loading...

    • +

      P08.03 - Cost‑Effectiveness of Pembrolizumab With or Without Chemotherapy for Stage IV Non‑Squamous NSCLC with High PD‑L1 in Switzerland

      00:00 - 00:00  |  Presenter: Esther Pardo

      • Abstract

      Loading...

    • +

      P08.04 - Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors

      00:00 - 00:00  |  Presenter: Lyudmila Bazhenova

      • Abstract

      Loading...

    • +

      P08.05 - Impact of Personal Characteristics on the Effectiveness of Immunotherapy Treatment in Late-Stage NSCLC: A Systematic Review

      00:00 - 00:00  |  Presenter: Krishna Patel

      • Abstract

      Loading...